NeoGenomics Inc (NEO)

9.11
0.06 0.66
NASDAQ : Health Care
Prev Close 9.05
Open 8.80
Day Low/High 8.79 / 9.28
52 Wk Low/High 5.26 / 9.54
Volume 443.50K
Avg Volume 535.80K
Exchange NASDAQ
Shares Outstanding 77.12M
Market Cap 713.34M
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Lock Down Gains in Big Winners

Keep accounts close to highs and don't give back gains.

NeoGenomics Deal With GE's Clarient 6 Months Later: Boom or Bust?

NeoGenomics Deal With GE's Clarient 6 Months Later: Boom or Bust?

The merger closed in December, which means enough time is passed to evaluate whether the acquisition was positive or negative.

NeoGenomics Becomes Oversold (NEO)

NeoGenomics Becomes Oversold (NEO)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Yellen's Words of Warning Don't Faze Market

It's unconcerned about rate hikes or the dollar.

Janet Yellen Could Upset Things Very Easily

Besides today, she has another speech coming up in early June.

Breadth Is Positive, and Semiconductors Are Leading the Charge

We are back to the old pattern of squeezing shorts and frustrating underinvested longs.

There's Some Life in Biotechnology Again

But the buying feels like it is contrarian-driven, to a fair extent.

There Is No Real Fear or Worry of a Major Correction

The price action doesn't look all that bad, so why not catch some dips?

NEO: Insiders vs. Shorts

NEO: Insiders vs. Shorts

The most recent short interest data was recently released by the NASDAQ for the 03/31/2016 settlement date, and NeoGenomics Inc is one of the most shorted stocks of the Russell 3000, based on 8.83 "days to cover" versus the median component at 5.89. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

NeoGenomics (NEO) Shares Cross Above 200 DMA

NeoGenomics (NEO) Shares Cross Above 200 DMA

In trading on Tuesday, shares of NeoGenomics Inc crossed above their 200 day moving average of $6.50, changing hands as high as $6.78 per share. NeoGenomics Inc shares are currently trading up about 2.4% on the day.

Commit To Buy NeoGenomics At $5, Earn 16.5% Annualized Using Options

Commit To Buy NeoGenomics At $5, Earn 16.5% Annualized Using Options

Investors considering a purchase of NeoGenomics Inc shares, but tentative about paying the going market price of $5.83/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the August put at the $5 strike, which has a bid at the time of this writing of 40 cents.

NeoGenomics Becomes Oversold (NEO)

NeoGenomics Becomes Oversold (NEO)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Oversold Conditions For NeoGenomics (NEO)

Oversold Conditions For NeoGenomics (NEO)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

NEO: Insiders vs. Shorts

NEO: Insiders vs. Shorts

The most recent short interest data was recently released by the NASDAQ for the 12/15/2015 settlement date, and NeoGenomics Inc is one of the most shorted stocks of the Russell 3000, based on 7.70 "days to cover" versus the median component at 5.46. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

Short Interest Falls 11% For NEO

Short Interest Falls 11% For NEO

The most recent short interest data has been released by the NASDAQ for the 10/30/2015 settlement date, which shows a 264,422 share decrease in total short interest for NeoGenomics Inc , to 2,165,826, a decrease of 10.88% since 10/15/2015. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan

Cramer will be watching for earnings from Priceline, McDonald's and Macy's in another busy week.

2 Longs and 2 Shorts to Watch in This Volatile Market

2 Longs and 2 Shorts to Watch in This Volatile Market

In this volatile market, we're going to look at charts trending both up and down.

NeoGenomics Signs Definitive Agreement To Acquire Clarient, Inc.

NeoGenomics Signs Definitive Agreement To Acquire Clarient, Inc.

GE Healthcare retains significant stake in NeoGenomics and Parties agree to collaborate on Bioinformatics Initiative

Interesting NEO Put And Call Options For May 2016

Interesting NEO Put And Call Options For May 2016

Investors in NeoGenomics Inc saw new options begin trading this week, for the May 2016 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 232 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.